Sign in
4

Changes in Ownership

Disc Medicine, Inc. Filed Acc 0000950170-23-070394

Chief Financial Officer sold 2,500 shares at $65.22 ($163,062)

  • Chief Financial Officer acquired 2,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bryce Joanne · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-12 Exercise or conversion : show line 1 in the form 10b5-1 +2,500 $2.65 $6,625 5,000 D
2023-12-12 Sale : show line 2 in the form 10b5-1 −2,500 $65.22 $163,062 2,500 D
Open-market sales · 2,500 sh · avg $65.22 · $163,062

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-12 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,500 2,253 D
Loading xslF345X05/ownership.xml…